SCHEMBL27015334

SCHEMBL27015334

C=C(C)c1ccc(CC)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
LMNA P02545 2/20 0.41
MAPK1 P28482 1/20 0.41
NLRP1 Q9C000 1/20 0.41
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
EPHX2 P34913 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
TSHR P16473 2/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
HSD17B1 P14061 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16960410 0.84 TAS1R3 (0.47) TAS1R3TAS1R1LMNAMAPK1NLRP1
SCHEMBL16728864 0.82 TAS1R3 (0.49) TAS1R3TAS1R1LMNAMAPK1NLRP1
SCHEMBL1362391 0.82 HSP90AA1 (0.38) HSP90AA1HSP90AB1HSD17B1MEN1HTT
SCHEMBL16951562 0.81 TAS1R3 (0.43) TAS1R3TAS1R1LMNAMAPK1NLRP1
SCHEMBL25531544 0.80 TAS1R3 (0.42) TAS1R3TAS1R1LMNAMAPK1NLRP1
SCHEMBL16957376 0.79 TAS1R3 (0.43) TAS1R3TAS1R1LMNAMAPK1NLRP1
SCHEMBL19291095 0.78 HSD17B1 (0.40) LMNAHSP90AA1HSP90AB1EPHX2HSD17B1
SCHEMBL17198001 0.78 TSHR (0.61) TAS1R3TAS1R1LMNAMAPK1NLRP1
SCHEMBL10336411 0.78 HSD17B1 (0.43) HSP90AA1HSP90AB1HSD17B1HTTPOLB
SCHEMBL16956386 0.78 TAS1R3 (0.43) TAS1R3TAS1R1LMNAMAPK1NLRP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016942-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016942-A1 STAT DEGRADERS AND USES THEREOF STAT4, STAT1, STAT3 TAS1R3 3999/4885TAS1R1 4104/4885LMNA 4438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.